Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 1744 CL Dose Finding in Asthma
NCT00467740Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of olodaterol in asthma, sponsored by Boehringer Ingelheim. Started May 2007; status: completed.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00467740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467740.